Cerebras still needs to come down further before it is worth buying. IPO stocks often rise sharply at first, then fall, and can take a long time to return to their original value, so entering at an expensive price right after the IPO is unappealing. The view is not entirely negative on Cerebras, and it should not be called a direct Nvidia rival. x.com 

Cerebras likely needs more time despite heavy bullishness around its earnings and a nice breakout on its recent-IPO chart. Last quarter's earnings disappointed, so a sudden blowout quarter was unlikely. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras risks falling further if the market takes a breather, because stocks that IPO in a red-hot bull market tend to get bid far above fair value and then drop precipitously, as Arm's IPO showed; Cerebras has already fallen some. Investors upset about missing an allocation should remember this, echoing @ram's point, relayed by @dee_bosa, that every stock gets back to its IPO price. x.com 

Cerebras and its customers likely accounted for many of the chip limitations alleged in the short report, so the report may be wrong. This is a suspicion without specific insight. Short interest rose 40.7% into the report to 19.86 million shares, or 8.4% of float. x.com  x.com 

Cerebras has fallen more than 50% from its IPO highs, like every other hot deal, and its investor event did not deliver the news longs wanted. FOMO buying into the IPO proved deadly. x.com  x.com 

Cerebras is likely heading lower after terrible earnings, with share unlocks about to add supply. Its valuation was so stretched that it couldn't afford a miss, and it apparently missed; a lot of hope was already built into the price. It could trade around $150 soon. x.com  x.com  x.com  x.com 

Culper Research's wafer-failure complaints do not justify shorting Cerebras at $100. The customer complaints sound illogical, although quality issues would not be surprising while the chips are in the early-adopter phase. x.com  x.com 

Cerebras is a name to stay far away from. It tanked after OpenAI said its new chip with Broadcom outperforms Nvidia's, underlining how heavily Cerebras is tied to OpenAI, a dependence that hurt Oracle. It is also a recent IPO, a good share of its stock is owned by OpenAI insiders, and it is insanely volatile. x.com